A Chicago-based company has raised $3.1 million to fund a clinical trial for its high-resolution imaging probes for cancer surgeons.
Diagnostic Photonics, which launched in 2011 at the University of Illinois at Urbana-Champaign, hopes its technology will prevent multiple surgeries for cancer patients. The company is focusing efforts first on breast cancer because about 25 percent of affected women undergo multiple surgeries after lumpectomy, according to a study conducted by the University of Wisconsin Carbone Cancer Center in Madison.
The repeat surgeries are often spurred by the “challenges of where does the cancer stop and normal tissues start,” said CEO and president Andrew Cittadine.